Pioneering Precision
in Antibody Discovery
tell us what you need, and we will deliver to you
With deep scientific expertise, Lxbio Ab
develops your project from discovery to delivery.
We accelerate your journey to success with cutting-edge technologies and expert-driven results.
Your Idea, Your Project, Our Mission
We specialize in antibody discovery, offering innovative solutions to accelerate your therapeutic and diagnostic projects.
With advanced technologies such as single B cell screening, hybridoma development,
and phage display, we deliver high-affinity, target-specific antibodies tailored to your needs.
By leveraging cutting-edge technology, experts’ team, and scalable production capabilities, Lxbio Ab offers customized, high-quality tailored solutions to your needs. This enables faster time to market, cost-effective production, and access to innovative therapeutic formats, all while ensuring regulatory compliance and minimizing capital investment.
Latest Antibody Technology
Accelerating Innovation in Antibody Discovery and Production with Cutting-Edge Expertise
Evolution in Antibody Discovery
Rapid High-Resolution Screening of Plasma B Cells to Identify Antibody Lead Candidates
Deliver anti-idiotypic antibodies with competitive ligand-blocking activity in half the time of a traditional hybridoma screen.
Discover a diverse panel of rare, high-affinity antibodies against antigens with a completely homologous off-target product, which could not be discovered by phage display.
Our develop specific binding assays to discover lead candidates against challenging membrane-bound targets in just 29 days.
From up to 12 weeks to less than 4 weeks
Reduce AbD timelines and downstream costs by screening B cells for function in a single day and taking only the best candidates forward.
Adapted from: Antibody Discovery (AbD) Rapid High-Resolution Screening of Plasma B Cells to Identify Antibody Lead Candidates Brochure. 2023 Bruker Corporation
Our Timelines Reducing Approach
Rapid Prototyping
Accelerated timelines from concept to lead candidate selection using streamlined processes and integrated discovery platforms.
Robust Characterization
Comprehensive analytical services, including epitope mapping, binding affinity studies, and functional assays to validate antibody candidates.
Cell Line Development
Proprietary high-yield, stable cell line development capabilities ensuring consistency and scalability for manufacturing.
Custom Solutions
Tailored preclinical development programs to meet specific client needs, ensuring smooth transitions from discovery to clinical phases.
Key Differentiators
Speed to Market
Accelerate your drug development timeline
with integrated, streamlined processes that reduce time and costs at each stage.
Risk Mitigation
Reduce development risks with comprehensive analytical support, robust quality systems, and regulatory expertise.
Cutting-edge Technologies
Leverage-advanced platforms such as phage display, hybridoma technology, and next-generation sequencing for antibody discovery, optimization, and engineering.
Innovative Engineering
Expertise in humanization, affinity maturation, and antibody-drug conjugate design to create highly specific and effective therapeutic antibodies.
